Incontinence News and Research

Latest Incontinence News and Research

Use of minimally invasive procedures for radical prostatectomy has advantages as well as complications

New research indicates that the use of minimally invasive procedures (including the use of robotic assistance) for radical prostatectomy, which have increased significantly in recent years, may shorten hospital stays and decrease respiratory and surgical complications, but may also result in an increased rate of certain complications, including incontinence and erectile dysfunction, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.

14 Oct 2009

Novasys Medical's Renessa named the most promising new product for 2009

Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that its Renessa® non-surgical treatment for female stress urinary incontinence (SUI) was inducted into the Phoenix Hall of Fame as the 2009 Most Promising New Product at the Phoenix Medical Device and Diagnostic Conference for Chief Executive Officers.

14 Oct 2009

Urodynamix Technologies commences uroNIRS 2000 pilot program

Urodynamix Technologies Ltd. today announces that it has commenced a pilot sales and marketing program with Cardinal Health for its uroNIRS 2000, an innovative technology for the non-invasive diagnosis of bladder conditions. The 90-day pilot program will be used to by Urodynamix and Cardinal Health to evaluate the viability of adding the uroNIRS 2000 to Cardinal Health's catalogue of offerings to the urology market.

8 Oct 2009

Minimally invasive sling operations for stress urinary incontinence found promising

New, less invasive surgical treatments for stress urinary incontinence in women are just as effective as traditional open surgical approaches, according to Cochrane Researchers. The researchers carried out a systematic review of trials comparing different surgical approaches to treating the condition.

7 Oct 2009

HRT may increase urinary incontinence in postmenopausal women

Grappling with the risks and benefits of hormone replacement therapy (HRT) is nothing new for postmenopausal women. Researchers have now added more fuel to the fire, with evidence that HRT could play a role in incontinence.

7 Oct 2009

Uroplasty's Urgent PC and Macroplastique presented at the International Continence Society Meeting

Uroplasty, Inc., a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today highlighted presentations, workshops and posters focused on its products at the 39th Annual Meeting of the International Continence Society Meeting (ICS), September 29 - October 3 in San Francisco.

7 Oct 2009

Fifth SEEM anniversary meeting to be held in Belgrade

On 9 and 10 October the anniversary South Eastern European Meeting (SEEM) will be held in the Yugoslav Drama Theatre (Jugoslovensko Dramsko Pozoriste) in Belgrade (RS). Professor Michael Marberger (Vienna, AT), chairman of the Regional Office of the European Association of Urology: "For the 5th time the SEEM will provide a platform where new experimental and clinical work from the region is presented to an international audience".

5 Oct 2009

Strengthening the pelvic floor muscles effective for older women with urinary incontinence

Researchers at Rush University Medical Center have found that a program of pelvic floor muscle exercises, combined with pelvic health education, can be an effective way to manage urinary incontinence in elderly women.

3 Oct 2009

Clinical study results of prostate cancer patients treated with CyberKnife Radiosurgery released

Accuray Incorporated, a global leader in the field of radiosurgery, announced today publication of results from a study of early stage prostate cancer patients treated with CyberKnife Radiosurgery.

1 Oct 2009

Urodynamix: Cross of 1,480,000 common shares effected through Canaccord Capital

Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that a cross of 1,480,000 common shares has been effected through Canaccord Capital Inc. at a sales price of $0.05 per common share.

30 Sep 2009

AMS’ products restore patient's pelvic health and their quality of life

American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the results of three major clinical studies that each point to a high degree of efficacy and patient satisfaction with AMS’ minimally invasive treatment options for female stress urinary incontinence (SUI) and vaginal prolapse.

30 Sep 2009

Effective decision support tools may help decide whether or not to undertake PSA screening

Although screening for prostate cancer with the Prostate Specific Antigen (PSA) test in men ages 50-70 can detect the cancer before it becomes symptomatic, knowing whether screening is beneficial for these men is uncertain.

30 Sep 2009

Urodynamix closes $1.5 million non-brokered private placement for common shares

Urodynamix Technologies Ltd. (TSX VENTURE:URO) is pleased to announce that it has closed a $1.5 million non-brokered private placement for 30,000,000 common shares previously reported on September 11, 2009.

29 Sep 2009

Quintiles Transnational enter into marketing agreement with Allergan for SANCTURA XR

Quintiles Transnational Corp. and Allergan, Inc. (NYSE: AGN) today announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR® (trospium chloride extended release capsules), an anticholinergic approved for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency, predominantly to primary care physicians in the United States.

28 Sep 2009

Initial clinical results for Mpathy Medical's Omnisure sling released

Mpathy Medical, a rapidly growing medical device company which has developed and brought to market a range of less invasive surgical solutions used to restore pelvic health to women, released the initial clinical results for its newest product, Omnisure™, a novel full length sling for treatment of female stress urinary incontinence (SUI) at the American Urogynecologic Society’s (AUGS) Annual Meeting.

26 Sep 2009

NHSSC awards contract to AMS to supply SUI treatment devices in UK

American Medical Systems (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that it has been included as part of a multiple-awardees contract by National Healthcare Services (NHS) Supply Chain (NHSSC) to supply three of its clinically-proven female stress urinary incontinence (SUI) treatment devices through the Normanton distribution centre, United Kingdom.

24 Sep 2009

Study compares benefits of laparoscopic and traditional open surgery for prostate cancer

The more things change, the more they stay the same, as the proverb goes. A study appearing in an upcoming edition of The Journal of Oncology appears to prove just that. The study compares the benefits of laparoscopic surgery versus traditional open surgery in the treatment of prostate cancer. With traditional surgery, surgeons remove the prostate gland via an incision below the belly button.

24 Sep 2009

Palmetto GBA-TrailBlazer Health cover Renessa treatment of female SUI

Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that Palmetto GBA and TrailBlazer Health Enterprises, LLC -- two large regional Medicare carriers serving over 10.2 million beneficiaries in California, Nevada, Hawaii, Texas, Oklahoma, Colorado, New Mexico and Virginia -- have agreed to cover the Renessa(R) treatment for female SUI (stress urinary incontinence) in appropriately selected patients with documented medical necessity.

24 Sep 2009

Women usually tightlipped about bladder problems

Women may be known as the more talkative sex, but when it comes to a certain sensitive health topic, their lips are sealed, according to a new "Bladder Talk" survey of 780 women aged 35 and older in North America (U.S. and Canada) sponsored by TENA(R), the worldwide leader in the management of bladder protection, and conducted by Harris Interactive.

24 Sep 2009

FemSoft from Rochester Medical included in the UK Drug Tariff

Rochester Medical Corporation (Nasdaq: ROCM) today announced that the Company's FemSoft(R) Insert has been approved for inclusion in Part IX of the UK Drug Tariff as a prescription product which is reimbursable.

22 Sep 2009

Incontinence News and Research

Latest Incontinence News and Research

Use of minimally invasive procedures for radical prostatectomy has advantages as well as complications

Novasys Medical's Renessa named the most promising new product for 2009

Urodynamix Technologies commences uroNIRS 2000 pilot program

Minimally invasive sling operations for stress urinary incontinence found promising

HRT may increase urinary incontinence in postmenopausal women

Uroplasty's Urgent PC and Macroplastique presented at the International Continence Society Meeting

Fifth SEEM anniversary meeting to be held in Belgrade

Strengthening the pelvic floor muscles effective for older women with urinary incontinence

Clinical study results of prostate cancer patients treated with CyberKnife Radiosurgery released

Urodynamix: Cross of 1,480,000 common shares effected through Canaccord Capital

AMS’ products restore patient's pelvic health and their quality of life

Effective decision support tools may help decide whether or not to undertake PSA screening

Urodynamix closes $1.5 million non-brokered private placement for common shares

Quintiles Transnational enter into marketing agreement with Allergan for SANCTURA XR

Initial clinical results for Mpathy Medical's Omnisure sling released

NHSSC awards contract to AMS to supply SUI treatment devices in UK

Study compares benefits of laparoscopic and traditional open surgery for prostate cancer

Palmetto GBA-TrailBlazer Health cover Renessa treatment of female SUI

Women usually tightlipped about bladder problems

FemSoft from Rochester Medical included in the UK Drug Tariff

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Incontinence News and Research

Latest Incontinence News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in